BofA raised the firm’s price target on Corteva (CTVA) to $73 from $69 and keeps a Buy rating on the shares. Although the ag economy remains soft, Corteva’s 2025 outlook was “solid,” the analyst tells investors. Amid significant uncertainty within the analyst’s ag and chemicals coverage, BofA believes Corteva offers “relative stability and double-digit EBITDA growth from several growth drivers” at “a reasonable valuation,” the analyst added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva’s Growth Potential and Competitive Edge Reinforce Buy Rating Despite Challenges
- Corteva price target raised to $72 from $70 at Oppenheimer
- Corteva’s Strong Execution and Growth Outlook Underpin Buy Rating Despite Exchange Headwinds
- Corteva price target raised to $70 from $68 at KeyBanc
- Corteva Reports Strong Q4 Driven by Crop Demand
Questions or Comments about the article? Write to editor@tipranks.com